During migration in tissue in vivo or in culture in a three-dimensional (3D) extracellular matrix (ECM), endothelial cells, fibroblasts and tumour cells exhibit a characteristic complex shape that ...

Myosin Marketing is hoping your desire to do some good in the world will supersede your annoyance at getting a random text. On Tuesday, Myosin, a self-described accelerator helping brands scale their ...

Myosin Therapeutics today announced it has been invited to present at two upcoming South Florida life sciences events highlighting emerging biotechnology innovation and regional industry growth. On ...

The novel cardiac myosin inhibitor aficamten improved peak oxygen uptake in symptomatic obstructive hypertrophic cardiomyopathy (HCM), the pivotal SEQUOIA-HCM trial showed. At 24 weeks, the mean ...

JUPITER, Fla., Aug. 19, 2025 /PRNewswire/ -- Myosin Therapeutics, a biotechnology company developing novel therapies for aggressive cancers, today announced it has been awarded a $4.5M Phase IIB ...

JUPITER, Fla., Feb. 26, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has closed its second seed funding ...

Austin, TX, July 30, 2024 – Myosin Marketing, a full-service growth marketing accelerator propelling brands to new heights through cutting-edge strategies and conscious business practices, today ...

The team showed with microsecond resolution that the head of myosin first binds weakly to actin. That bond strengthens, however, as myosin moves along the actin filament and finds the position for ...

Each year, about 14,000 people in the United States are diagnosed with glioblastoma, one of the deadliest primary brain tumors. With standard treatments of surgery, radiation, and chemotherapy ...

Using technologies like electron microscopy (EM) it is possible to capture molecular mechanisms in great detail, but not when these mechanisms are currently moving. The field of cryomicroscopy ...

"This process appears to be regulated by myosin-binding protein-C (cMyBP-C), which is a heart muscle protein," study author Kerry McDonald said. "Our study investigated its role in cardiac muscle ...